These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 37114737)

  • 1. Circular RNAs in the chemoresistance of triple-negative breast cancer: A systematic review.
    Wang H; Shan X; Peng Y; Zhou W
    Drug Dev Res; 2023 Aug; 84(5):805-814. PubMed ID: 37114737
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CircRNA-CREIT inhibits stress granule assembly and overcomes doxorubicin resistance in TNBC by destabilizing PKR.
    Wang X; Chen T; Li C; Li W; Zhou X; Li Y; Luo D; Zhang N; Chen B; Wang L; Zhao W; Fu S; Yang Q
    J Hematol Oncol; 2022 Aug; 15(1):122. PubMed ID: 36038948
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circular RNAs as novel biomarkers in triple-negative breast cancer: a systematic review.
    Foruzandeh Z; Dorabadi DG; Sadeghi F; Zeinali-Sehrig F; Zaefizadeh M; Rahmati Y; Alivand MR
    Mol Biol Rep; 2022 Oct; 49(10):9825-9840. PubMed ID: 35534586
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CircWAC induces chemotherapeutic resistance in triple-negative breast cancer by targeting miR-142, upregulating WWP1 and activating the PI3K/AKT pathway.
    Wang L; Zhou Y; Jiang L; Lu L; Dai T; Li A; Chen Y; Zhang L
    Mol Cancer; 2021 Mar; 20(1):43. PubMed ID: 33648498
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hijacking 5-Fluorouracil Chemoresistance in Triple Negative Breast Cancer via microRNAs-Loaded Chitosan Nanoparticles.
    Fahmy SA; Mahdy NK; Mohamed AH; Mokhtar FA; Youness RA
    Int J Mol Sci; 2024 Feb; 25(4):. PubMed ID: 38396746
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hsa_circ_0000199 facilitates chemo-tolerance of triple-negative breast cancer by interfering with miR-206/613-led PI3K/Akt/mTOR signaling.
    Li H; Xu W; Xia Z; Liu W; Pan G; Ding J; Li J; Wang J; Xie X; Jiang D
    Aging (Albany NY); 2021 Jan; 13(3):4522-4551. PubMed ID: 33495420
    [TBL] [Abstract][Full Text] [Related]  

  • 7. circUSP42 Is Downregulated in Triple-Negative Breast Cancer and Associated With Poor Prognosis.
    Yu J; Shen W; Xu J; Gong B; Gao B; Zhu J
    Technol Cancer Res Treat; 2020; 19():1533033820950827. PubMed ID: 32938310
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CircRNA_0044556 diminishes the sensitivity of triple‑negative breast cancer cells to adriamycin by sponging miR‑145 and regulating NRAS.
    Chen J; Shi P; Zhang J; Li Y; Ma J; Zhang Y; Liu H
    Mol Med Rep; 2022 Feb; 25(2):. PubMed ID: 34913063
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Down-regulating GRP78 reverses pirarubicin resistance of triple negative breast cancer by miR-495-3p mimics and involves the p-AKT/mTOR pathway.
    Liu M; Yang J; Lv W; Wang S; Du T; Zhang K; Wu Y; Feng X
    Biosci Rep; 2022 Jan; 42(1):. PubMed ID: 34935899
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CircTRIM1 encodes TRIM1-269aa to promote chemoresistance and metastasis of TNBC via enhancing CaM-dependent MARCKS translocation and PI3K/AKT/mTOR activation.
    Li Y; Wang Z; Yang J; Sun Y; He Y; Wang Y; Chen X; Liang Y; Zhang N; Wang X; Zhao W; Hu G; Yang Q
    Mol Cancer; 2024 May; 23(1):102. PubMed ID: 38755678
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA profiling implies new markers of chemoresistance of triple-negative breast cancer.
    Ouyang M; Li Y; Ye S; Ma J; Lu L; Lv W; Chang G; Li X; Li Q; Wang S; Wang W
    PLoS One; 2014; 9(5):e96228. PubMed ID: 24788655
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Noncoding RNAs in triple negative breast cancer: Mechanisms for chemoresistance.
    Xia M; Zu X; Chen Z; Wen G; Zhong J
    Cancer Lett; 2021 Dec; 523():100-110. PubMed ID: 34601022
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of Circ_0000977-Mediated Regulatory Network in Breast Cancer: A Potential Discriminative Biomarker for Triple-Negative Tumors.
    Darbeheshti F; Mansoori Y; Azizi-Tabesh G; Zolfaghari F; Kadkhoda S; Rasti A; Rezaei N; Shakoori A
    Biochem Genet; 2023 Aug; 61(4):1487-1508. PubMed ID: 36645554
    [TBL] [Abstract][Full Text] [Related]  

  • 14. circGFRA1 affects the sensitivity of triple-negative breast cancer cells to paclitaxel via the miR-361-5p/TLR4 pathway.
    Zheng SR; Huang QD; Zheng ZH; Zhang ZT; Guo GL
    J Biochem; 2021 Jul; 169(5):601-611. PubMed ID: 33481008
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circular RNA UBAP2 facilitates the cisplatin resistance of triple-negative breast cancer via microRNA-300/anti-silencing function 1B histone chaperone/PI3K/AKT/mTOR axis.
    Wang L; Yang X; Zhou F; Sun X; Li S
    Bioengineered; 2022 Mar; 13(3):7197-7208. PubMed ID: 35263216
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The functional significance and cross-talk of non-coding RNAs in triple negative and quadruple negative breast cancer.
    Paul U; Banerjee S
    Mol Biol Rep; 2022 Jul; 49(7):6899-6918. PubMed ID: 35235157
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Progress of non-coding RNAs in triple-negative breast cancer.
    Liu J; Zhao G; Liu XL; Zhang G; Zhao SQ; Zhang SL; Luo LH; Yin DC; Zhang CY
    Life Sci; 2021 May; 272():119238. PubMed ID: 33600860
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulatory mechanisms, functions, and clinical significance of CircRNAs in triple-negative breast cancer.
    Lyu L; Zhang S; Deng Y; Wang M; Deng X; Yang S; Wu Y; Dai Z
    J Hematol Oncol; 2021 Mar; 14(1):41. PubMed ID: 33676555
    [TBL] [Abstract][Full Text] [Related]  

  • 19. circKIF4A acts as a prognostic factor and mediator to regulate the progression of triple-negative breast cancer.
    Tang H; Huang X; Wang J; Yang L; Kong Y; Gao G; Zhang L; Chen ZS; Xie X
    Mol Cancer; 2019 Feb; 18(1):23. PubMed ID: 30744636
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CircDUSP1 regulates tumor growth, metastasis, and paclitaxel sensitivity in triple-negative breast cancer by targeting miR-761/DACT2 signaling axis.
    Huang S; Xie J; Lei S; Fan P; Zhang C; Huang Z
    Mol Carcinog; 2023 Apr; 62(4):450-463. PubMed ID: 36562476
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.